nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—CYP1A2—Estropipate—osteoporosis	0.126	0.53	CbGbCtD
Guanabenz—CYP1A2—Conjugated Estrogens—osteoporosis	0.0597	0.251	CbGbCtD
Guanabenz—CYP1A2—Estradiol—osteoporosis	0.0525	0.22	CbGbCtD
Guanabenz—Dermatitis—Etidronic acid—osteoporosis	0.000531	0.000778	CcSEcCtD
Guanabenz—Syncope—Conjugated Estrogens—osteoporosis	0.00053	0.000775	CcSEcCtD
Guanabenz—Hypertension—Zoledronate—osteoporosis	0.00053	0.000775	CcSEcCtD
Guanabenz—Hypersensitivity—Alendronate—osteoporosis	0.000529	0.000775	CcSEcCtD
Guanabenz—Headache—Etidronic acid—osteoporosis	0.000528	0.000773	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000525	0.000769	CcSEcCtD
Guanabenz—Asthenia—Estropipate—osteoporosis	0.000524	0.000766	CcSEcCtD
Guanabenz—Anorexia—Pamidronate—osteoporosis	0.000523	0.000765	CcSEcCtD
Guanabenz—Arthralgia—Zoledronate—osteoporosis	0.000522	0.000764	CcSEcCtD
Guanabenz—Myalgia—Zoledronate—osteoporosis	0.000522	0.000764	CcSEcCtD
Guanabenz—Chest pain—Zoledronate—osteoporosis	0.000522	0.000764	CcSEcCtD
Guanabenz—Anxiety—Zoledronate—osteoporosis	0.000521	0.000762	CcSEcCtD
Guanabenz—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000519	0.00076	CcSEcCtD
Guanabenz—Paraesthesia—Risedronate—osteoporosis	0.000518	0.000758	CcSEcCtD
Guanabenz—Pruritus—Estropipate—osteoporosis	0.000516	0.000756	CcSEcCtD
Guanabenz—Discomfort—Zoledronate—osteoporosis	0.000516	0.000755	CcSEcCtD
Guanabenz—Asthenia—Alendronate—osteoporosis	0.000516	0.000755	CcSEcCtD
Guanabenz—Hypersensitivity—Ibandronate—osteoporosis	0.000516	0.000755	CcSEcCtD
Guanabenz—Cough—Conjugated Estrogens—osteoporosis	0.000515	0.000755	CcSEcCtD
Guanabenz—Dyspnoea—Risedronate—osteoporosis	0.000514	0.000752	CcSEcCtD
Guanabenz—Erythema multiforme—Estradiol—osteoporosis	0.000514	0.000752	CcSEcCtD
Guanabenz—Hypotension—Pamidronate—osteoporosis	0.000512	0.00075	CcSEcCtD
Guanabenz—Dry mouth—Zoledronate—osteoporosis	0.000511	0.000748	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000511	0.000747	CcSEcCtD
Guanabenz—Fatigue—Ethinyl Estradiol—osteoporosis	0.00051	0.000746	CcSEcCtD
Guanabenz—Pruritus—Alendronate—osteoporosis	0.000508	0.000744	CcSEcCtD
Guanabenz—Dyspepsia—Risedronate—osteoporosis	0.000508	0.000743	CcSEcCtD
Guanabenz—Eye disorder—Estradiol—osteoporosis	0.000508	0.000743	CcSEcCtD
Guanabenz—Tinnitus—Estradiol—osteoporosis	0.000506	0.000741	CcSEcCtD
Guanabenz—Constipation—Ethinyl Estradiol—osteoporosis	0.000506	0.00074	CcSEcCtD
Guanabenz—Confusional state—Zoledronate—osteoporosis	0.000505	0.000739	CcSEcCtD
Guanabenz—Hypersensitivity—Calcitriol—osteoporosis	0.000505	0.000739	CcSEcCtD
Guanabenz—Arthralgia—Conjugated Estrogens—osteoporosis	0.000503	0.000736	CcSEcCtD
Guanabenz—Myalgia—Conjugated Estrogens—osteoporosis	0.000503	0.000736	CcSEcCtD
Guanabenz—Chest pain—Conjugated Estrogens—osteoporosis	0.000503	0.000736	CcSEcCtD
Guanabenz—Asthenia—Ibandronate—osteoporosis	0.000502	0.000735	CcSEcCtD
Guanabenz—Anxiety—Conjugated Estrogens—osteoporosis	0.000501	0.000734	CcSEcCtD
Guanabenz—Nausea—Etidronic acid—osteoporosis	0.000501	0.000733	CcSEcCtD
Guanabenz—Oedema—Zoledronate—osteoporosis	0.000501	0.000733	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000499	0.000731	CcSEcCtD
Guanabenz—Diarrhoea—Estropipate—osteoporosis	0.000499	0.000731	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Risedronate—osteoporosis	0.000498	0.000729	CcSEcCtD
Guanabenz—Infection—Zoledronate—osteoporosis	0.000497	0.000728	CcSEcCtD
Guanabenz—Fatigue—Risedronate—osteoporosis	0.000497	0.000728	CcSEcCtD
Guanabenz—Pruritus—Ibandronate—osteoporosis	0.000495	0.000725	CcSEcCtD
Guanabenz—Pain—Risedronate—osteoporosis	0.000493	0.000722	CcSEcCtD
Guanabenz—Constipation—Risedronate—osteoporosis	0.000493	0.000722	CcSEcCtD
Guanabenz—Shock—Zoledronate—osteoporosis	0.000493	0.000721	CcSEcCtD
Guanabenz—Paraesthesia—Pamidronate—osteoporosis	0.000492	0.00072	CcSEcCtD
Guanabenz—Diarrhoea—Alendronate—osteoporosis	0.000492	0.00072	CcSEcCtD
Guanabenz—Asthenia—Calcitriol—osteoporosis	0.000491	0.000719	CcSEcCtD
Guanabenz—Nervous system disorder—Zoledronate—osteoporosis	0.000491	0.000719	CcSEcCtD
Guanabenz—Immune system disorder—Estradiol—osteoporosis	0.000491	0.000718	CcSEcCtD
Guanabenz—Thrombocytopenia—Zoledronate—osteoporosis	0.00049	0.000718	CcSEcCtD
Guanabenz—Mediastinal disorder—Estradiol—osteoporosis	0.000489	0.000716	CcSEcCtD
Guanabenz—Dyspnoea—Pamidronate—osteoporosis	0.000489	0.000715	CcSEcCtD
Guanabenz—Tachycardia—Zoledronate—osteoporosis	0.000489	0.000715	CcSEcCtD
Guanabenz—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000487	0.000713	CcSEcCtD
Guanabenz—Chills—Estradiol—osteoporosis	0.000487	0.000713	CcSEcCtD
Guanabenz—Skin disorder—Zoledronate—osteoporosis	0.000486	0.000712	CcSEcCtD
Guanabenz—Pruritus—Calcitriol—osteoporosis	0.000485	0.000709	CcSEcCtD
Guanabenz—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000484	0.000708	CcSEcCtD
Guanabenz—Diarrhoea—Raloxifene—osteoporosis	0.000484	0.000708	CcSEcCtD
Guanabenz—Dyspepsia—Pamidronate—osteoporosis	0.000483	0.000706	CcSEcCtD
Guanabenz—Dizziness—Estropipate—osteoporosis	0.000483	0.000706	CcSEcCtD
Guanabenz—Oedema—Conjugated Estrogens—osteoporosis	0.000482	0.000706	CcSEcCtD
Guanabenz—Infection—Conjugated Estrogens—osteoporosis	0.000479	0.000701	CcSEcCtD
Guanabenz—Diarrhoea—Ibandronate—osteoporosis	0.000479	0.000701	CcSEcCtD
Guanabenz—Anorexia—Zoledronate—osteoporosis	0.000477	0.000699	CcSEcCtD
Guanabenz—Decreased appetite—Pamidronate—osteoporosis	0.000477	0.000697	CcSEcCtD
Guanabenz—Dizziness—Alendronate—osteoporosis	0.000475	0.000696	CcSEcCtD
Guanabenz—Shock—Conjugated Estrogens—osteoporosis	0.000474	0.000694	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000473	0.000693	CcSEcCtD
Guanabenz—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000473	0.000692	CcSEcCtD
Guanabenz—Malnutrition—Estradiol—osteoporosis	0.000473	0.000692	CcSEcCtD
Guanabenz—Erythema—Estradiol—osteoporosis	0.000473	0.000692	CcSEcCtD
Guanabenz—Fatigue—Pamidronate—osteoporosis	0.000473	0.000692	CcSEcCtD
Guanabenz—Gastrointestinal pain—Risedronate—osteoporosis	0.000472	0.00069	CcSEcCtD
Guanabenz—Tachycardia—Conjugated Estrogens—osteoporosis	0.000471	0.000689	CcSEcCtD
Guanabenz—Urticaria—Ethinyl Estradiol—osteoporosis	0.00047	0.000688	CcSEcCtD
Guanabenz—Pain—Pamidronate—osteoporosis	0.000469	0.000686	CcSEcCtD
Guanabenz—Constipation—Pamidronate—osteoporosis	0.000469	0.000686	CcSEcCtD
Guanabenz—Diarrhoea—Calcitriol—osteoporosis	0.000469	0.000686	CcSEcCtD
Guanabenz—Skin disorder—Conjugated Estrogens—osteoporosis	0.000468	0.000685	CcSEcCtD
Guanabenz—Hypotension—Zoledronate—osteoporosis	0.000468	0.000685	CcSEcCtD
Guanabenz—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000468	0.000684	CcSEcCtD
Guanabenz—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000468	0.000684	CcSEcCtD
Guanabenz—Dizziness—Raloxifene—osteoporosis	0.000467	0.000684	CcSEcCtD
Guanabenz—Flatulence—Estradiol—osteoporosis	0.000466	0.000682	CcSEcCtD
Guanabenz—Tension—Estradiol—osteoporosis	0.000464	0.000679	CcSEcCtD
Guanabenz—Vomiting—Estropipate—osteoporosis	0.000464	0.000679	CcSEcCtD
Guanabenz—Dizziness—Ibandronate—osteoporosis	0.000463	0.000677	CcSEcCtD
Guanabenz—Rash—Estropipate—osteoporosis	0.00046	0.000673	CcSEcCtD
Guanabenz—Dermatitis—Estropipate—osteoporosis	0.00046	0.000673	CcSEcCtD
Guanabenz—Anorexia—Conjugated Estrogens—osteoporosis	0.00046	0.000673	CcSEcCtD
Guanabenz—Nervousness—Estradiol—osteoporosis	0.000459	0.000672	CcSEcCtD
Guanabenz—Urticaria—Risedronate—osteoporosis	0.000458	0.00067	CcSEcCtD
Guanabenz—Back pain—Estradiol—osteoporosis	0.000457	0.000669	CcSEcCtD
Guanabenz—Headache—Estropipate—osteoporosis	0.000457	0.000669	CcSEcCtD
Guanabenz—Vomiting—Alendronate—osteoporosis	0.000457	0.000669	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000456	0.000668	CcSEcCtD
Guanabenz—Body temperature increased—Risedronate—osteoporosis	0.000456	0.000667	CcSEcCtD
Guanabenz—Abdominal pain—Risedronate—osteoporosis	0.000456	0.000667	CcSEcCtD
Guanabenz—Muscle spasms—Estradiol—osteoporosis	0.000455	0.000665	CcSEcCtD
Guanabenz—Rash—Alendronate—osteoporosis	0.000453	0.000663	CcSEcCtD
Guanabenz—Dermatitis—Alendronate—osteoporosis	0.000453	0.000663	CcSEcCtD
Guanabenz—Feeling abnormal—Pamidronate—osteoporosis	0.000452	0.000661	CcSEcCtD
Guanabenz—Hypotension—Conjugated Estrogens—osteoporosis	0.000451	0.000659	CcSEcCtD
Guanabenz—Headache—Alendronate—osteoporosis	0.00045	0.000659	CcSEcCtD
Guanabenz—Paraesthesia—Zoledronate—osteoporosis	0.00045	0.000658	CcSEcCtD
Guanabenz—Vomiting—Raloxifene—osteoporosis	0.000449	0.000658	CcSEcCtD
Guanabenz—Gastrointestinal pain—Pamidronate—osteoporosis	0.000448	0.000656	CcSEcCtD
Guanabenz—Dyspnoea—Zoledronate—osteoporosis	0.000446	0.000653	CcSEcCtD
Guanabenz—Rash—Raloxifene—osteoporosis	0.000446	0.000652	CcSEcCtD
Guanabenz—Dermatitis—Raloxifene—osteoporosis	0.000445	0.000652	CcSEcCtD
Guanabenz—Vomiting—Ibandronate—osteoporosis	0.000445	0.000651	CcSEcCtD
Guanabenz—Headache—Raloxifene—osteoporosis	0.000443	0.000648	CcSEcCtD
Guanabenz—Rash—Ibandronate—osteoporosis	0.000441	0.000646	CcSEcCtD
Guanabenz—Dermatitis—Ibandronate—osteoporosis	0.000441	0.000645	CcSEcCtD
Guanabenz—Dyspepsia—Zoledronate—osteoporosis	0.000441	0.000645	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000439	0.000643	CcSEcCtD
Guanabenz—Ill-defined disorder—Estradiol—osteoporosis	0.000439	0.000642	CcSEcCtD
Guanabenz—Headache—Ibandronate—osteoporosis	0.000438	0.000642	CcSEcCtD
Guanabenz—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000436	0.000638	CcSEcCtD
Guanabenz—Vomiting—Calcitriol—osteoporosis	0.000435	0.000637	CcSEcCtD
Guanabenz—Decreased appetite—Zoledronate—osteoporosis	0.000435	0.000637	CcSEcCtD
Guanabenz—Agitation—Estradiol—osteoporosis	0.000434	0.000636	CcSEcCtD
Guanabenz—Nausea—Estropipate—osteoporosis	0.000433	0.000634	CcSEcCtD
Guanabenz—Abdominal pain—Pamidronate—osteoporosis	0.000433	0.000634	CcSEcCtD
Guanabenz—Body temperature increased—Pamidronate—osteoporosis	0.000433	0.000634	CcSEcCtD
Guanabenz—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000433	0.000634	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000432	0.000633	CcSEcCtD
Guanabenz—Angioedema—Estradiol—osteoporosis	0.000432	0.000632	CcSEcCtD
Guanabenz—Rash—Calcitriol—osteoporosis	0.000432	0.000632	CcSEcCtD
Guanabenz—Fatigue—Zoledronate—osteoporosis	0.000432	0.000632	CcSEcCtD
Guanabenz—Dermatitis—Calcitriol—osteoporosis	0.000431	0.000632	CcSEcCtD
Guanabenz—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00043	0.000629	CcSEcCtD
Guanabenz—Headache—Calcitriol—osteoporosis	0.000429	0.000628	CcSEcCtD
Guanabenz—Pain—Zoledronate—osteoporosis	0.000428	0.000627	CcSEcCtD
Guanabenz—Constipation—Zoledronate—osteoporosis	0.000428	0.000627	CcSEcCtD
Guanabenz—Nausea—Alendronate—osteoporosis	0.000427	0.000625	CcSEcCtD
Guanabenz—Malaise—Estradiol—osteoporosis	0.000426	0.000624	CcSEcCtD
Guanabenz—Hypersensitivity—Risedronate—osteoporosis	0.000425	0.000622	CcSEcCtD
Guanabenz—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000424	0.000621	CcSEcCtD
Guanabenz—Asthenia—Ethinyl Estradiol—osteoporosis	0.000424	0.000621	CcSEcCtD
Guanabenz—Syncope—Estradiol—osteoporosis	0.000424	0.000621	CcSEcCtD
Guanabenz—Nausea—Raloxifene—osteoporosis	0.00042	0.000614	CcSEcCtD
Guanabenz—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000419	0.000613	CcSEcCtD
Guanabenz—Pruritus—Ethinyl Estradiol—osteoporosis	0.000418	0.000612	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000416	0.000609	CcSEcCtD
Guanabenz—Fatigue—Conjugated Estrogens—osteoporosis	0.000416	0.000608	CcSEcCtD
Guanabenz—Nausea—Ibandronate—osteoporosis	0.000416	0.000608	CcSEcCtD
Guanabenz—Loss of consciousness—Estradiol—osteoporosis	0.000416	0.000608	CcSEcCtD
Guanabenz—Asthenia—Risedronate—osteoporosis	0.000414	0.000606	CcSEcCtD
Guanabenz—Feeling abnormal—Zoledronate—osteoporosis	0.000413	0.000604	CcSEcCtD
Guanabenz—Cough—Estradiol—osteoporosis	0.000413	0.000604	CcSEcCtD
Guanabenz—Pain—Conjugated Estrogens—osteoporosis	0.000412	0.000603	CcSEcCtD
Guanabenz—Constipation—Conjugated Estrogens—osteoporosis	0.000412	0.000603	CcSEcCtD
Guanabenz—Gastrointestinal pain—Zoledronate—osteoporosis	0.000409	0.000599	CcSEcCtD
Guanabenz—Hypertension—Estradiol—osteoporosis	0.000408	0.000597	CcSEcCtD
Guanabenz—Pruritus—Risedronate—osteoporosis	0.000408	0.000597	CcSEcCtD
Guanabenz—Nausea—Calcitriol—osteoporosis	0.000407	0.000595	CcSEcCtD
Guanabenz—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000405	0.000592	CcSEcCtD
Guanabenz—Hypersensitivity—Pamidronate—osteoporosis	0.000404	0.000591	CcSEcCtD
Guanabenz—Chest pain—Estradiol—osteoporosis	0.000403	0.000589	CcSEcCtD
Guanabenz—Arthralgia—Estradiol—osteoporosis	0.000403	0.000589	CcSEcCtD
Guanabenz—Myalgia—Estradiol—osteoporosis	0.000403	0.000589	CcSEcCtD
Guanabenz—Anxiety—Estradiol—osteoporosis	0.000401	0.000587	CcSEcCtD
Guanabenz—Urticaria—Zoledronate—osteoporosis	0.000398	0.000582	CcSEcCtD
Guanabenz—Discomfort—Estradiol—osteoporosis	0.000398	0.000582	CcSEcCtD
Guanabenz—Abdominal pain—Zoledronate—osteoporosis	0.000396	0.000579	CcSEcCtD
Guanabenz—Body temperature increased—Zoledronate—osteoporosis	0.000396	0.000579	CcSEcCtD
Guanabenz—Diarrhoea—Risedronate—osteoporosis	0.000395	0.000577	CcSEcCtD
Guanabenz—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000394	0.000577	CcSEcCtD
Guanabenz—Dry mouth—Estradiol—osteoporosis	0.000394	0.000576	CcSEcCtD
Guanabenz—Asthenia—Pamidronate—osteoporosis	0.000393	0.000576	CcSEcCtD
Guanabenz—Dizziness—Ethinyl Estradiol—osteoporosis	0.000391	0.000572	CcSEcCtD
Guanabenz—Confusional state—Estradiol—osteoporosis	0.000389	0.000569	CcSEcCtD
Guanabenz—Pruritus—Pamidronate—osteoporosis	0.000388	0.000568	CcSEcCtD
Guanabenz—Oedema—Estradiol—osteoporosis	0.000386	0.000565	CcSEcCtD
Guanabenz—Infection—Estradiol—osteoporosis	0.000383	0.000561	CcSEcCtD
Guanabenz—Urticaria—Conjugated Estrogens—osteoporosis	0.000383	0.000561	CcSEcCtD
Guanabenz—Dizziness—Risedronate—osteoporosis	0.000381	0.000558	CcSEcCtD
Guanabenz—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000381	0.000558	CcSEcCtD
Guanabenz—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000381	0.000558	CcSEcCtD
Guanabenz—Shock—Estradiol—osteoporosis	0.00038	0.000556	CcSEcCtD
Guanabenz—Nervous system disorder—Estradiol—osteoporosis	0.000378	0.000554	CcSEcCtD
Guanabenz—Tachycardia—Estradiol—osteoporosis	0.000377	0.000551	CcSEcCtD
Guanabenz—Vomiting—Ethinyl Estradiol—osteoporosis	0.000376	0.00055	CcSEcCtD
Guanabenz—Diarrhoea—Pamidronate—osteoporosis	0.000375	0.000549	CcSEcCtD
Guanabenz—Skin disorder—Estradiol—osteoporosis	0.000375	0.000549	CcSEcCtD
Guanabenz—Rash—Ethinyl Estradiol—osteoporosis	0.000373	0.000546	CcSEcCtD
Guanabenz—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000373	0.000545	CcSEcCtD
Guanabenz—Headache—Ethinyl Estradiol—osteoporosis	0.000371	0.000542	CcSEcCtD
Guanabenz—Hypersensitivity—Zoledronate—osteoporosis	0.000369	0.00054	CcSEcCtD
Guanabenz—Vomiting—Risedronate—osteoporosis	0.000367	0.000537	CcSEcCtD
Guanabenz—Rash—Risedronate—osteoporosis	0.000364	0.000532	CcSEcCtD
Guanabenz—Dermatitis—Risedronate—osteoporosis	0.000363	0.000532	CcSEcCtD
Guanabenz—Dizziness—Pamidronate—osteoporosis	0.000362	0.000531	CcSEcCtD
Guanabenz—Headache—Risedronate—osteoporosis	0.000361	0.000529	CcSEcCtD
Guanabenz—Asthenia—Zoledronate—osteoporosis	0.000359	0.000526	CcSEcCtD
Guanabenz—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000355	0.00052	CcSEcCtD
Guanabenz—Pruritus—Zoledronate—osteoporosis	0.000354	0.000518	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000352	0.000515	CcSEcCtD
Guanabenz—Nausea—Ethinyl Estradiol—osteoporosis	0.000351	0.000514	CcSEcCtD
Guanabenz—Vomiting—Pamidronate—osteoporosis	0.000349	0.00051	CcSEcCtD
Guanabenz—Paraesthesia—Estradiol—osteoporosis	0.000346	0.000507	CcSEcCtD
Guanabenz—Asthenia—Conjugated Estrogens—osteoporosis	0.000346	0.000506	CcSEcCtD
Guanabenz—Rash—Pamidronate—osteoporosis	0.000346	0.000506	CcSEcCtD
Guanabenz—Dermatitis—Pamidronate—osteoporosis	0.000345	0.000505	CcSEcCtD
Guanabenz—Dyspnoea—Estradiol—osteoporosis	0.000344	0.000504	CcSEcCtD
Guanabenz—Headache—Pamidronate—osteoporosis	0.000343	0.000503	CcSEcCtD
Guanabenz—Diarrhoea—Zoledronate—osteoporosis	0.000343	0.000501	CcSEcCtD
Guanabenz—Nausea—Risedronate—osteoporosis	0.000343	0.000501	CcSEcCtD
Guanabenz—Pruritus—Conjugated Estrogens—osteoporosis	0.000341	0.000499	CcSEcCtD
Guanabenz—Dyspepsia—Estradiol—osteoporosis	0.00034	0.000497	CcSEcCtD
Guanabenz—Decreased appetite—Estradiol—osteoporosis	0.000335	0.000491	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Estradiol—osteoporosis	0.000333	0.000488	CcSEcCtD
Guanabenz—Fatigue—Estradiol—osteoporosis	0.000333	0.000487	CcSEcCtD
Guanabenz—Dizziness—Zoledronate—osteoporosis	0.000331	0.000485	CcSEcCtD
Guanabenz—Pain—Estradiol—osteoporosis	0.00033	0.000483	CcSEcCtD
Guanabenz—Constipation—Estradiol—osteoporosis	0.00033	0.000483	CcSEcCtD
Guanabenz—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00033	0.000483	CcSEcCtD
Guanabenz—Nausea—Pamidronate—osteoporosis	0.000326	0.000477	CcSEcCtD
Guanabenz—Dizziness—Conjugated Estrogens—osteoporosis	0.000319	0.000467	CcSEcCtD
Guanabenz—Vomiting—Zoledronate—osteoporosis	0.000318	0.000466	CcSEcCtD
Guanabenz—Feeling abnormal—Estradiol—osteoporosis	0.000318	0.000465	CcSEcCtD
Guanabenz—Rash—Zoledronate—osteoporosis	0.000316	0.000462	CcSEcCtD
Guanabenz—Gastrointestinal pain—Estradiol—osteoporosis	0.000316	0.000462	CcSEcCtD
Guanabenz—Dermatitis—Zoledronate—osteoporosis	0.000315	0.000462	CcSEcCtD
Guanabenz—Headache—Zoledronate—osteoporosis	0.000314	0.000459	CcSEcCtD
Guanabenz—Vomiting—Conjugated Estrogens—osteoporosis	0.000307	0.000449	CcSEcCtD
Guanabenz—Urticaria—Estradiol—osteoporosis	0.000307	0.000449	CcSEcCtD
Guanabenz—Body temperature increased—Estradiol—osteoporosis	0.000305	0.000446	CcSEcCtD
Guanabenz—Abdominal pain—Estradiol—osteoporosis	0.000305	0.000446	CcSEcCtD
Guanabenz—Rash—Conjugated Estrogens—osteoporosis	0.000304	0.000445	CcSEcCtD
Guanabenz—Dermatitis—Conjugated Estrogens—osteoporosis	0.000304	0.000445	CcSEcCtD
Guanabenz—Headache—Conjugated Estrogens—osteoporosis	0.000302	0.000442	CcSEcCtD
Guanabenz—Nausea—Zoledronate—osteoporosis	0.000297	0.000435	CcSEcCtD
Guanabenz—Nausea—Conjugated Estrogens—osteoporosis	0.000286	0.000419	CcSEcCtD
Guanabenz—Hypersensitivity—Estradiol—osteoporosis	0.000284	0.000416	CcSEcCtD
Guanabenz—Asthenia—Estradiol—osteoporosis	0.000277	0.000405	CcSEcCtD
Guanabenz—Pruritus—Estradiol—osteoporosis	0.000273	0.0004	CcSEcCtD
Guanabenz—Diarrhoea—Estradiol—osteoporosis	0.000264	0.000386	CcSEcCtD
Guanabenz—Dizziness—Estradiol—osteoporosis	0.000255	0.000373	CcSEcCtD
Guanabenz—Vomiting—Estradiol—osteoporosis	0.000245	0.000359	CcSEcCtD
Guanabenz—Rash—Estradiol—osteoporosis	0.000243	0.000356	CcSEcCtD
Guanabenz—Dermatitis—Estradiol—osteoporosis	0.000243	0.000356	CcSEcCtD
Guanabenz—Headache—Estradiol—osteoporosis	0.000242	0.000354	CcSEcCtD
Guanabenz—Nausea—Estradiol—osteoporosis	0.000229	0.000335	CcSEcCtD
Guanabenz—ADRA2C—Metabolism—ATIC—osteoporosis	0.000137	0.00175	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—FGA—osteoporosis	0.000134	0.00171	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SOST—osteoporosis	0.000132	0.00169	CbGpPWpGaD
Guanabenz—ADRA2C—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000132	0.00169	CbGpPWpGaD
Guanabenz—ADRA2C—G alpha (i) signalling events—POMC—osteoporosis	0.000131	0.00167	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—MGLL—osteoporosis	0.000131	0.00167	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PKM—osteoporosis	0.000129	0.00164	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—FDPS—osteoporosis	0.000129	0.00164	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CALCR—osteoporosis	0.000128	0.00164	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PTH1R—osteoporosis	0.000128	0.00164	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—PTH—osteoporosis	0.000125	0.0016	CbGpPWpGaD
Guanabenz—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	0.000125	0.0016	CbGpPWpGaD
Guanabenz—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	0.000125	0.0016	CbGpPWpGaD
Guanabenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	0.000125	0.00159	CbGpPWpGaD
Guanabenz—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	0.000124	0.00158	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—CALCA—osteoporosis	0.000123	0.00157	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—CNR2—osteoporosis	0.000122	0.00156	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—FGB—osteoporosis	0.000122	0.00156	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PGLS—osteoporosis	0.000122	0.00156	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GPD2—osteoporosis	0.000122	0.00156	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PTH1R—osteoporosis	0.00012	0.00153	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CALCR—osteoporosis	0.00012	0.00153	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000118	0.0015	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—PTH—osteoporosis	0.000117	0.0015	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—OXCT1—osteoporosis	0.000117	0.00149	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—CA2—osteoporosis	0.000117	0.00149	CbGpPWpGaD
Guanabenz—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	0.000116	0.00149	CbGpPWpGaD
Guanabenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	0.000116	0.00149	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000115	0.00146	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—CNR2—osteoporosis	0.000114	0.00146	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—PTH—osteoporosis	0.000114	0.00146	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—MGLL—osteoporosis	0.000114	0.00145	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ATIC—osteoporosis	0.000111	0.00142	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PNP—osteoporosis	0.000111	0.00142	CbGpPWpGaD
Guanabenz—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000111	0.00142	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CNR2—osteoporosis	0.000111	0.00142	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SOST—osteoporosis	0.000108	0.00137	CbGpPWpGaD
Guanabenz—ADRA2A—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000107	0.00137	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—PTH—osteoporosis	0.000106	0.00136	CbGpPWpGaD
Guanabenz—ADRA2A—G alpha (i) signalling events—POMC—osteoporosis	0.000106	0.00136	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—WNT1—osteoporosis	0.000104	0.00133	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—PTHLH—osteoporosis	0.000104	0.00133	CbGpPWpGaD
Guanabenz—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000104	0.00133	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CNR2—osteoporosis	0.000104	0.00132	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MGLL—osteoporosis	0.000102	0.0013	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—LRP5—osteoporosis	9.94e-05	0.00127	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—WNT1—osteoporosis	9.75e-05	0.00125	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CALCR—osteoporosis	9.72e-05	0.00124	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PTH1R—osteoporosis	9.72e-05	0.00124	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—PTHLH—osteoporosis	9.71e-05	0.00124	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—IDH2—osteoporosis	9.67e-05	0.00123	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PTH—osteoporosis	9.52e-05	0.00122	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MGLL—osteoporosis	9.51e-05	0.00121	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—LRP6—osteoporosis	9.5e-05	0.00121	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—OXCT1—osteoporosis	9.48e-05	0.00121	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CA2—osteoporosis	9.48e-05	0.00121	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—PTHLH—osteoporosis	9.44e-05	0.00121	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—LRP5—osteoporosis	9.28e-05	0.00119	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CNR2—osteoporosis	9.28e-05	0.00118	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—MGLL—osteoporosis	9.24e-05	0.00118	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—CALCA—osteoporosis	9.15e-05	0.00117	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	9.15e-05	0.00117	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—CYP27A1—osteoporosis	9.09e-05	0.00116	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—LRP6—osteoporosis	8.88e-05	0.00113	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—ACP5—osteoporosis	8.84e-05	0.00113	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—PTHLH—osteoporosis	8.82e-05	0.00113	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PTH—osteoporosis	8.65e-05	0.0011	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—CALCA—osteoporosis	8.55e-05	0.00109	CbGpPWpGaD
Guanabenz—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	8.48e-05	0.00108	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR ligand binding—POMC—osteoporosis	8.48e-05	0.00108	CbGpPWpGaD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	8.44e-05	0.00108	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CNR2—osteoporosis	8.43e-05	0.00108	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CALCA—osteoporosis	8.31e-05	0.00106	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—TPI1—osteoporosis	8.22e-05	0.00105	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TLN1—osteoporosis	8.03e-05	0.00102	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—WNT1—osteoporosis	7.92e-05	0.00101	CbGpPWpGaD
Guanabenz—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	7.92e-05	0.00101	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—POMC—osteoporosis	7.92e-05	0.00101	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PTHLH—osteoporosis	7.89e-05	0.00101	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—IDH2—osteoporosis	7.85e-05	0.001	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	7.78e-05	0.000994	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CALCA—osteoporosis	7.77e-05	0.000992	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—P4HB—osteoporosis	7.73e-05	0.000987	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MGLL—osteoporosis	7.72e-05	0.000986	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—GAPDH—osteoporosis	7.59e-05	0.000969	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LRP5—osteoporosis	7.54e-05	0.000963	CbGpPWpGaD
Guanabenz—CYP1A2—Biological oxidations—POMC—osteoporosis	7.53e-05	0.000961	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TLN1—osteoporosis	7.5e-05	0.000957	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—RAP1A—osteoporosis	7.39e-05	0.000944	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CYP27A1—osteoporosis	7.39e-05	0.000943	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—IGF1—osteoporosis	7.29e-05	0.000931	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LRP6—osteoporosis	7.21e-05	0.000921	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ACP5—osteoporosis	7.18e-05	0.000917	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PTHLH—osteoporosis	7.16e-05	0.000915	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—FDPS—osteoporosis	7.1e-05	0.000906	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PKM—osteoporosis	7.1e-05	0.000906	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CALCA—osteoporosis	6.95e-05	0.000887	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—P4HB—osteoporosis	6.92e-05	0.000884	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—IGF1—osteoporosis	6.81e-05	0.00087	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PTH—osteoporosis	6.73e-05	0.00086	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PGLS—osteoporosis	6.73e-05	0.000859	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GPD2—osteoporosis	6.73e-05	0.000859	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—TPI1—osteoporosis	6.68e-05	0.000853	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—RAP1A—osteoporosis	6.62e-05	0.000845	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CNR2—osteoporosis	6.56e-05	0.000838	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—ADCY5—osteoporosis	6.51e-05	0.000832	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—P4HB—osteoporosis	6.46e-05	0.000825	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NFATC1—osteoporosis	6.45e-05	0.000824	CbGpPWpGaD
Guanabenz—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	6.43e-05	0.000821	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—POMC—osteoporosis	6.43e-05	0.000821	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—DKK1—osteoporosis	6.4e-05	0.000818	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CALCA—osteoporosis	6.31e-05	0.000805	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PTH—osteoporosis	6.29e-05	0.000803	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—P4HB—osteoporosis	6.28e-05	0.000802	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—RAP1A—osteoporosis	6.18e-05	0.000789	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—WNT1—osteoporosis	6.17e-05	0.000788	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GAPDH—osteoporosis	6.16e-05	0.000787	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PNP—osteoporosis	6.15e-05	0.000786	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ATIC—osteoporosis	6.15e-05	0.000786	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CNR2—osteoporosis	6.13e-05	0.000783	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TLN1—osteoporosis	6.09e-05	0.000778	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—ADCY5—osteoporosis	6.08e-05	0.000777	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NFATC1—osteoporosis	6.03e-05	0.00077	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—RAP1A—osteoporosis	6e-05	0.000767	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—FGA—osteoporosis	6e-05	0.000766	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—DKK1—osteoporosis	5.98e-05	0.000764	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—ENO1—osteoporosis	5.97e-05	0.000763	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—ADCY5—osteoporosis	5.91e-05	0.000755	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PSMA2—osteoporosis	5.89e-05	0.000752	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PSMA5—osteoporosis	5.89e-05	0.000752	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—WNT1—osteoporosis	5.76e-05	0.000736	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—FGA—osteoporosis	5.6e-05	0.000716	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PTHLH—osteoporosis	5.58e-05	0.000712	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—BMP2—osteoporosis	5.58e-05	0.000712	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—IGF1—osteoporosis	5.53e-05	0.000706	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—ADCY5—osteoporosis	5.52e-05	0.000705	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—FGB—osteoporosis	5.46e-05	0.000697	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PSMA5—osteoporosis	5.27e-05	0.000673	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PSMA2—osteoporosis	5.27e-05	0.000673	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—P4HB—osteoporosis	5.25e-05	0.00067	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—OXCT1—osteoporosis	5.23e-05	0.000668	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CA2—osteoporosis	5.23e-05	0.000668	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PTHLH—osteoporosis	5.21e-05	0.000665	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—BMP2—osteoporosis	5.21e-05	0.000665	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PTH—osteoporosis	5.11e-05	0.000652	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—MGLL—osteoporosis	5.1e-05	0.000651	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—FGB—osteoporosis	5.1e-05	0.000651	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—RAP1A—osteoporosis	5.02e-05	0.000641	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CNR2—osteoporosis	4.98e-05	0.000636	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—ADCY5—osteoporosis	4.94e-05	0.000631	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PSMA2—osteoporosis	4.92e-05	0.000629	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PSMA5—osteoporosis	4.92e-05	0.000629	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CALCA—osteoporosis	4.91e-05	0.000627	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NFATC1—osteoporosis	4.9e-05	0.000625	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—DKK1—osteoporosis	4.86e-05	0.00062	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ENO1—osteoporosis	4.85e-05	0.00062	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.81e-05	0.000614	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—POMC—osteoporosis	4.79e-05	0.000612	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PSMA2—osteoporosis	4.78e-05	0.000611	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PSMA5—osteoporosis	4.78e-05	0.000611	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—CYP19A1—osteoporosis	4.78e-05	0.00061	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—WNT1—osteoporosis	4.68e-05	0.000598	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CALCA—osteoporosis	4.59e-05	0.000586	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FGA—osteoporosis	4.55e-05	0.000581	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—ADCY5—osteoporosis	4.49e-05	0.000573	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—POMC—osteoporosis	4.47e-05	0.000571	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—KL—osteoporosis	4.46e-05	0.000569	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—TGFB1—osteoporosis	4.37e-05	0.000558	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—POMC—osteoporosis	4.35e-05	0.000555	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—IDH2—osteoporosis	4.34e-05	0.000554	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—IL6R—osteoporosis	4.24e-05	0.000542	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	4.23e-05	0.00054	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—BMP2—osteoporosis	4.23e-05	0.00054	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—KL—osteoporosis	4.17e-05	0.000532	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FGB—osteoporosis	4.14e-05	0.000529	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—TGFB1—osteoporosis	4.08e-05	0.000521	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP27A1—osteoporosis	4.08e-05	0.000521	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—POMC—osteoporosis	4.06e-05	0.000519	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	4e-05	0.000511	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	4e-05	0.000511	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ACP5—osteoporosis	3.97e-05	0.000506	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—IL6R—osteoporosis	3.96e-05	0.000506	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.92e-05	0.0005	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—ADCY5—osteoporosis	3.9e-05	0.000498	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—GPX1—osteoporosis	3.89e-05	0.000497	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CYP19A1—osteoporosis	3.88e-05	0.000495	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CALCA—osteoporosis	3.73e-05	0.000476	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—TPI1—osteoporosis	3.69e-05	0.000471	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	3.63e-05	0.000464	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—MTHFR—osteoporosis	3.59e-05	0.000458	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	3.49e-05	0.000446	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—P4HB—osteoporosis	3.47e-05	0.000443	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GAPDH—osteoporosis	3.4e-05	0.000434	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—KL—osteoporosis	3.38e-05	0.000432	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—SPP1—osteoporosis	3.38e-05	0.000432	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—TGFB1—osteoporosis	3.32e-05	0.000423	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—RAP1A—osteoporosis	3.31e-05	0.000423	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—POMC—osteoporosis	3.3e-05	0.000421	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	3.26e-05	0.000417	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	3.22e-05	0.000411	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ADCY5—osteoporosis	3.17e-05	0.000405	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GPX1—osteoporosis	3.16e-05	0.000403	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SPP1—osteoporosis	3.16e-05	0.000403	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IRS2—osteoporosis	3.06e-05	0.00039	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—LEP—osteoporosis	2.99e-05	0.000382	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—MTHFR—osteoporosis	2.92e-05	0.000372	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.89e-05	0.000369	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—POMC—osteoporosis	2.87e-05	0.000367	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—ESR1—osteoporosis	2.86e-05	0.000365	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IRS2—osteoporosis	2.86e-05	0.000365	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—LEP—osteoporosis	2.79e-05	0.000357	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ENO1—osteoporosis	2.68e-05	0.000342	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IRS1—osteoporosis	2.67e-05	0.000341	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ESR1—osteoporosis	2.67e-05	0.000341	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	2.65e-05	0.000338	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PSMA5—osteoporosis	2.64e-05	0.000337	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PSMA2—osteoporosis	2.64e-05	0.000337	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—POMC—osteoporosis	2.57e-05	0.000328	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SPP1—osteoporosis	2.56e-05	0.000327	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL6R—osteoporosis	2.51e-05	0.00032	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IRS1—osteoporosis	2.49e-05	0.000318	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IGF1—osteoporosis	2.47e-05	0.000316	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—POMC—osteoporosis	2.4e-05	0.000306	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL6R—osteoporosis	2.34e-05	0.000299	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—POMC—osteoporosis	2.33e-05	0.000298	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IRS2—osteoporosis	2.32e-05	0.000296	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IGF1—osteoporosis	2.31e-05	0.000295	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LEP—osteoporosis	2.27e-05	0.00029	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ESR1—osteoporosis	2.17e-05	0.000277	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP19A1—osteoporosis	2.14e-05	0.000273	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IRS1—osteoporosis	2.02e-05	0.000259	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—POMC—osteoporosis	1.95e-05	0.000249	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL6R—osteoporosis	1.9e-05	0.000243	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—IL6—osteoporosis	1.89e-05	0.000241	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IGF1—osteoporosis	1.88e-05	0.000239	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—IL6—osteoporosis	1.77e-05	0.000225	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ADCY5—osteoporosis	1.75e-05	0.000223	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GPX1—osteoporosis	1.74e-05	0.000223	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—MTHFR—osteoporosis	1.61e-05	0.000205	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MYC—osteoporosis	1.49e-05	0.00019	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	1.48e-05	0.000189	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—IL6—osteoporosis	1.43e-05	0.000183	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MYC—osteoporosis	1.39e-05	0.000177	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	1.38e-05	0.000177	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—POMC—osteoporosis	1.29e-05	0.000164	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MYC—osteoporosis	1.13e-05	0.000144	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	1.12e-05	0.000144	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL6—osteoporosis	1.12e-05	0.000143	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL6—osteoporosis	1.04e-05	0.000133	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL6—osteoporosis	8.47e-06	0.000108	CbGpPWpGaD
